FXN 3-in-1 Strip (Powder/Liquid)

A rapid test for detecting benzodiazepines in liquid and powder samples for harm reduction purposes. The test provides quick identification of benzodiazepine presence.

Rapid immunoassay test strip for simultaneous detection of fentanyl and xylazine in urine specimens. Designed for point-of-care drug screening in occupational health, clinical, and harm reduction settings. Results obtained within minutes with visual interpretation.

A rapid diagnostic test strip for detecting fentanyl in powder samples. Provides quick identification of this potent opioid for substance analysis and safety purposes.

FDA-cleared rapid dual immunoassay test for simultaneous detection of fentanyl and norfentanyl in biological specimens. Designed for drug screening in clinical and point-of-care settings, enabling fast, reliable results to support substance use monitoring and pain management protocols.

Rapid immunoassay test for qualitative detection of fentanyl in urine or other biological samples. Designed for point-of-care screening in clinical, occupational health, and substance monitoring settings. Delivers results in minutes using a simple test strip format requiring minimal sample volume.

CLIA-waived rapid immunofluorescence assay test kit for qualitative detection of fentanyl in human specimens. Enables point-of-care screening in clinical, forensic, and workplace testing environments with fast turnaround time. 510(k) cleared and designed for use with oral fluid or other body matrices.

FDA 510(k) cleared and CLIA waived rapid drug screening test for fentanyl and its primary metabolite norfentanyl. Delivers results in 5 minutes using urine specimens with cut-off levels of 1 ng/mL for fentanyl and 5 ng/mL for norfentanyl. Suitable for point-of-care and over-the-counter use with 24-month shelf life.

A rapid diagnostic test strip capable of detecting multiple drugs of abuse simultaneously in urine samples. Provides comprehensive and accurate multi-drug screening results.

CLIA-waived rapid diagnostic test kit for fentanyl screening in oral fluid samples. FDA 510(k) cleared for point-of-care and laboratory use, enabling quick identification of fentanyl presence for substance use disorder monitoring and overdose prevention programs.

FDA-cleared (K231904) lateral flow immunoassay achieving over 99% accuracy for fentanyl detection in urine at 1 ng/mL cutoff concentration. Used for drug screening and toxicology applications.

Rapid test strip for xylazine detection with 1000 ng/mL cutoff level. Designed for forensic and substance abuse screening applications with straightforward testing procedure.

FDA-cleared rapid test for detecting fentanyl and its metabolite norfentanyl in home settings. Provides quick results for substance identification and harm reduction purposes. Single-use format designed for ease of use and safety.